Suitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
YTD | 1 Month | 3 Months | 1 Years | 3 Years | 5 Years | 10 Years | |
---|---|---|---|---|---|---|---|
Fund | 5.53 | 3.75 | 6.17 | 5.53 | -- | -- | -- |
S&P BSE Healthcare TRI | -3.19 | 3.27 | 2.76 | -2.71 | -- | -- | -- |
Equity: Sectoral-Pharma | 4.03 | 3.31 | 4.71 | 4.40 | -- | -- | -- |
Rank within category | 4 | 2 | 1 | 4 | -- | -- | -- |
Number of funds in category | 7 | 9 | 9 | 7 | 4 | 3 | 0 |
As on 13-Dec-2019
Best (Period) | Worst (Period) | |
---|---|---|
Month | 10.28 (07-Oct-2019 - 07-Nov-2019) | -8.80 (07-Sep-2018 - 08-Oct-2018) |
Quarter | 7.28 (05-Aug-2019 - 04-Nov-2019) | -10.80 (07-Sep-2018 - 07-Dec-2018) |
Year | 1.88 (06-Nov-2018 - 07-Nov-2019) | -10.86 (28-Aug-2018 - 28-Aug-2019) |
Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
---|---|---|---|---|---|---|
Fund | -- | -- | -- | -- | -- | -- |
S&P BSE Healthcare TRI* | -2.70 | 17.56 | -0.48 | -0.84 | -- | -- |
Equity: Sectoral-Pharma* | 1.05 | 15.77 | -0.29 | -0.50 | 0.85 | 2.52 |
Rank within category | -- | -- | -- | -- | -- | -- |
Number of funds in category | -- | -- | -- | -- | -- | -- |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on
* As on 30-Nov-2019
Please wait...
Number of Stocks | 31 |
Top 10 Stocks (%) | 60.12 |
Top 5 Stocks (%) | 38.27 |
Top 3 Sectors (%) | 95.65 |
Portfolio P/B Ratio | 2.60 |
Portfolio P/E Ratio | 25.64 |
Fund | Benchmark | Category* | |
---|---|---|---|
Average Mkt Cap (Rs Cr) | 19,319 | 23,516 | |
Giant (%) | -- | -- | |
Large (%) | 33.17 | 35.74 | |
Mid (%) | 45.67 | 51.60 | |
Small (%) | 21.16 | 12.65 | |
Tiny (%) | -- | -- |
Please wait...
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 30-Nov-2019
— Ihab Dalwai since 25-Jun-2018
Education: Mr. Dalwai is a Chartered Accountant.
Experience: He is associated with ICICI Prudential AMC since April 2011.
Funds Managed:
Personal finance advice and mutual fund ideas delivered to your inbox every Monday
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Minimum Investment (₹) | 5,000 |
Minimum Addl Investment (₹) | 1,000 |
Minimum SIP Investment (₹) | 100 |
Minimum No of Cheques | 6 |
Minimum Withdrawal (₹) | 500 |
Minimum Balance (₹) | -- |
Exit Load | 1% for redemption within 15 days |
Fund House: | ICICI Prudential Mutual Fund |
Launch Date: | 13-Jul-2018 |
Benchmark: | S&P BSE Healthcare TRI |
Riskometer: | High |
Type: | Open-ended |
Assets: | ₹ 1,327 Cr (As on 30-Nov-2019) |
Expense: | 0.81% (As on 31-Oct-2019) |
Risk Grade: | -- |
Return Grade: | -- |
Turnover: | -- |
Fund News - 20-Dec-2018
Fund News - 29-Oct-2018
Monthly SIP Amount changes in Schemes of ICICI Prudential Mutual Fund
AMC: ICICI Prudential Asset Management Company Ltd
Address: One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai - 400051
Phone: 022-26525000 / 1800-222-999 / 1800-200-6666
Fax: 022-26528100
Email: [email protected]
Website: www.icicipruamc.com
Registrar & Transfer Agent: Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002
Phone: 1800-3010-6767 / 1800-419-7676
Fax: 044-30407101
Email: [email protected]
Website: www.camsonline.com